TY - JOUR
T1 - Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases
AU - McIver, Edward G.
AU - Bryans, Justin
AU - Birchall, Kristian
AU - Chugh, Jasveen
AU - Drake, Thomas
AU - Lewis, Stephen J.
AU - Osborne, Joanne
AU - Smiljanic-Hurley, Ela
AU - Tsang, William
AU - Kamal, Ahmad
AU - Levy, Alison
AU - Newman, Michelle
AU - Taylor, Debra
AU - Arthur, J. Simon C.
AU - Clark, Kristopher
AU - Cohen, Philip
N1 - Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/12
Y1 - 2012/12
N2 - The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclopropyl pyrimidines is described. Starting from BX795, originally reported to be a potent inhibitor of PDK1, we have developed compounds with improved selectivity and drug-like properties. These compounds have been evaluated in a range of cellular and in vivo assays, enabling us to probe the putative role of the TBK1/IKKe pathway in inflammatory diseases.
AB - The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclopropyl pyrimidines is described. Starting from BX795, originally reported to be a potent inhibitor of PDK1, we have developed compounds with improved selectivity and drug-like properties. These compounds have been evaluated in a range of cellular and in vivo assays, enabling us to probe the putative role of the TBK1/IKKe pathway in inflammatory diseases.
UR - http://www.scopus.com/inward/record.url?scp=84867608938&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2012.09.063
DO - 10.1016/j.bmcl.2012.09.063
M3 - Article
SN - 0960-894X
VL - 22
SP - 7169
EP - 7173
JO - Bioorganic & Medicinal Chemistry Letters
JF - Bioorganic & Medicinal Chemistry Letters
IS - 23
ER -